Zellgesundheit verstehen – gesund älter werden

Søraas A, Engvig A, Alnæs D, Karim LN, Danilova E, Istre MS, et al. Interstitial fluid rejuvenation through young-donor plasma exchange in cognitively impaired patients: a pilot safety and feasibility study. GeroScience. 2026 Jul 23. DOI: 10.1007/s11357-026-02435-0

Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell. 2015 Jul;17(1):11–22. DOI: 10.1016/j.stem.2015.06.007

Mao AS, Mooney DJ. Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci USA. 2015 Nov 24;112(47):14452–9. DOI: 10.1073/pnas.1508520112

Clevers H. Modeling Development and Disease with Organoids. Cell. 2016 Jun;165(7):1586–97. DOI: 10.1016/j.cell.2016.05.082

Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genetics in Medicine. 2018 Oct;20(10):1122–30. DOI: 10.1038/gim.2017.247

Mach F, Koskinas KC, Roeters Van Lennep JE, Tokgözoğlu L, Badimon L, Baigent C, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2025 Nov 7;46(42):4359–78. DOI: 10.1093/eurheartj/ehaf190

Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014 Nov 28;346(6213):1258096. DOI: 10.1126/science.1258096

Frangoul H, Altshuler D, Cappellini MD, Chen YS, Domm J, Eustace BK, et al. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. N Engl J Med. 2021 Jan 21;384(3):252–60. DOI: 10.1056/NEJMoa2031054

Vafai SB, Täubel J, Ashdown T, Patel RS, Diamondali S, Cegla J, et al. In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia. N Engl J Med. 2026 Aug 13;395(7):648–59. DOI: 10.1056/NEJMoa2601283

Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, Maecker H, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. 2019 Dec;18(6):e13028. DOI: 10.1111/acel.13028

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021 Aug 26;596(7873):583–9. DOI: 10.1038/s41586-021-03819-2

Paine PT, Nguyen A, Ocampo A. Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology. Aging Cell. 2024 Feb;23(2):e14039. DOI: 10.1111/acel.14039

Mullard A. Calico, Alphabet’s anti-ageing play, goes it alone. Nat Rev Drug Discov. 2026 Jan;25(1):14–5. DOI: 10.1038/d41573-025-00205-9

Katsoulakis E, Wang Q, Wu H, Shahriyari L, Fletcher R, Liu J, et al. Digital twins for health: a scoping review. npj Digit Med. 2024 Mar 22;7(1):77. DOI: 10.1038/s41746-024-01073-0

De Magalhães JP. Why genes extending lifespan in model organisms have not been consistently associated with human longevity and what it means to translation research. Cell Cycle. 2014 Sep 2;13(17):2671–3. DOI: 10.4161/15384101.2014.950151

Khoury MJ, Bowen S, Dotson WD, Drzymalla E, Green RF, Goldstein R, et al. Health equity in the implementation of genomics and precision medicine: A public health imperative. Genetics in Medicine. 2022 Aug;24(8):1630–9. DOI: 10.1016/j.gim.2022.04.009

Joshi M, Singh S, Rowley N. Science of longevity medicine. BMJ. 2025 Dec 12;391:r2536. DOI: 10.1136/bmj.r2536

Shenhar B, Pridham G, De Oliveira TL, et al. Heritability of intrinsic human life span is about 50% when confounding factors are addressed. Science. 2026;391(6784):504–510. DOI: 10.1126/science.adz1187

Europäische Kommission. Delegierte Verordnung (EU) 2022/2104 über Vermarktungsnormen für Olivenöl, Artikel 10. https://eur-lex.europa.eu/eli/reg_del/2022/2104/oj/eng (abgerufen am 14.09.2026).

Monteiro CA, Cannon G, Levy RB, et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutrition. 2019;22(5):936–941. DOI: 10.1017/S1368980018003762